CASI Pharmaceuticals

CASI

NASDAQHealth Care

Income Statement

Total Revenue$28.54M

Gross Profit$11.15M

Operating Income$-39.43M

EBITDA$-101.76M

EBIT$-37.98M

Pre-tax Income$0

Net Income$-39.26M

Net Cash$0

Cash Equivalent$14.16M

Total Debt$14.12M

Net Debt$14.12M

Book Value$12.22M

Book Value Per Share0.88

Return on Equity (ROE)-2120.91%

Return on Assets (ROA)-73.14%

Return on Invested Capital (ROI)-194.00%

Net Profit Margin-137.57%

Current Ratio1.09

Quick Ratio0.86

Long-Term Debt / Equity0.00